A prospective diagnostic accuracy study in an emergency department found that noninvasive hemoglobin monitoring using pulse CO-oximeters cannot reliably replace central lab blood tests. The Rad-97 and Rad-67 devices delivered faster readings, but agreement with laboratory analyzers varied widely, with tendencies to overestimate hemoglobin in severe anemia. In the 861-patient cohort, nearly 36% had confirmed anemia, and the limits of agreement were broad, particularly at hemoglobin levels below 8.0 g/dL. Both devices showed proportional bias in the low range, limiting safe replacement for time-critical decisions. The data provide a direct evidence checkpoint for manufacturers and hospital procurement teams evaluating point-of-care hemoglobin workflows.
Get the Daily Brief